Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Ez Access

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 1417 mg/30 mL
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
August 5, 2016
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 1417 mg/30 mL
Other brand names
Dosage form
Liquid
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
August 5, 2016
Manufacturer
Product Max Group Inc
Registration number
part348
NDC root
70742-001
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

EZ ACCESS is a desensitizing spray specifically designed for temporary relief of pain or soreness in the perianal area. It contains benzocaine, which is a local anesthetic that helps numb the affected area, providing comfort when you need it most. This product is available in a 1.0 FL OZ (30mL) bottle and is distributed by BodyAction Products.

If you're experiencing discomfort in the perianal region, EZ ACCESS may offer you the relief you seek, allowing you to go about your day with greater ease. For more information, you can visit the manufacturer's website at www.bodyactionproducts.com.

Uses

If you're experiencing pain or soreness in the perianal area, this medication can provide temporary relief. It's designed to help ease discomfort, allowing you to feel more comfortable in your daily activities. Always consult with a healthcare professional if you have any questions or concerns about your symptoms.

Dosage and Administration

To use this product effectively, start by cleaning the affected area with mild soap and water. Make sure to rinse it thoroughly to remove any soap residue. After cleansing, gently dry the area by patting or blotting it with a tissue or a soft cloth.

Once the area is dry, you can apply the product. You can use it up to six times a day, depending on your needs. Just remember to follow these steps each time for the best results.

What to Avoid

It's important to be aware of specific instructions regarding the use of this medication. If you accidentally swallow it, seek medical help immediately or contact a Poison Control Center. This is crucial for your safety.

Currently, there are no listed contraindications, controlled substance classifications, or concerns about abuse, misuse, or dependence (a condition where your body becomes reliant on a substance). However, always follow the guidance provided to ensure safe use.

Side Effects

You may experience allergic reactions to some ingredients in this product. If you notice any symptoms such as redness, irritation, swelling, or pain that do not improve, or if these symptoms worsen, it’s important to stop using the product and consult your doctor. Your health and safety are paramount, so please pay attention to how your body responds.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to your eyes. Some individuals may experience allergic reactions to the ingredients. If you notice that the symptoms you are treating do not improve, or if you develop redness, irritation, swelling, pain, or any other concerning symptoms, stop using the product and consult your doctor.

In case of accidental ingestion, it is important to seek medical help immediately or contact a Poison Control Center. Your safety is a priority, so please take these precautions seriously.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have any concerns about your health.

Pregnancy Use

Currently, there is no available information about the use of EZ ACCESS - benzocaine liquid during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been established. If you are pregnant or planning to become pregnant, it is essential to consult your healthcare provider before using this product to ensure your safety and the safety of your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

It's important to keep this medication out of reach of children. If a child accidentally swallows it, you should seek medical help immediately or contact a Poison Control Center. Taking quick action can help ensure their safety. Always be vigilant and store medications securely to prevent any accidents.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and effective for you.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help you understand how to manage your treatment effectively.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, every individual is different, and your healthcare provider can help ensure that your treatment is safe and effective for you. Always feel free to ask questions and share your complete list of medications and any tests you may be undergoing.

Storage and Handling

To ensure your product is safe and effective, always check that the safety tab is intact before use. If the safety tab is broken or missing, do not use the product, as this could compromise its safety. Proper handling is crucial, so make sure to follow these guidelines to maintain the integrity of the device.

Additional Information

No further information is available.

FAQ

What is EZ ACCESS?

EZ ACCESS is an anal desensitizer that comes in the form of a benzocaine anorectal spray.

What is EZ ACCESS used for?

It is used for temporary relief of pain or soreness in the perianal area.

How should I use EZ ACCESS?

Cleanse the affected area with mild soap and water, dry it gently, and apply the spray up to 6 times daily.

Are there any contraindications for using EZ ACCESS?

No contraindications are listed for EZ ACCESS.

What should I do if I swallow EZ ACCESS?

If swallowed, get medical help or contact a Poison Control Center right away.

What precautions should I take when using EZ ACCESS?

Use it for external use only, avoid contact with the eyes, and discontinue use if you experience allergic reactions or if symptoms worsen.

Is there any information about using EZ ACCESS during pregnancy or while nursing?

There are no specific warnings or recommendations regarding the use of EZ ACCESS during pregnancy or lactation.

What should I do if the safety tab on EZ ACCESS is broken or missing?

Do not use EZ ACCESS if the safety tab is broken or missing.

Where can I find more information about EZ ACCESS?

You can visit the website www.bodyactionproducts.com for more information.

Packaging Info

Below are the non-prescription pack sizes of Ez Access (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ez Access.
Details

Drug Information (PDF)

This file contains official product information for Ez Access, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Benzo caine Anorectal Spray is an anal desensitizer formulated for topical application. This desensitizing spray is available in a 1.0 fluid ounce (30 mL) dosage form. It is distributed by BodyAction Products, located in Lutz, Florida, 33559. For additional information, visit www.bodyactionproducts.com.

Uses and Indications

This drug is indicated for the temporary relief of pain or soreness in the perianal area.

Dosage and Administration

When practical, the affected area should be cleansed with mild soap and water, followed by thorough rinsing. After cleansing, the area must be gently dried by patting or blotting with a tissue or a soft cloth prior to the application of the product. The product may be applied to the affected area up to 6 times daily, ensuring that the application is performed with care to maximize efficacy and minimize irritation.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, medical assistance should be sought immediately or contact a Poison Control Center.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes to prevent irritation or injury.

Allergic reactions may occur in certain individuals due to the ingredients in this product. Should the symptom being treated not improve, or if any adverse reactions such as redness, irritation, swelling, or pain develop or worsen, it is essential to discontinue use immediately and consult a healthcare professional.

In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients may experience allergic reactions to ingredients in this product. Symptoms such as redness, irritation, swelling, or pain may occur. If the symptom being treated does not improve or if any of these adverse reactions develop or worsen, patients are advised to discontinue use and consult a healthcare professional.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Ez Access (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ez Access.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of EZ ACCESS - benzocaine liquid during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when administering this product to pregnant patients. Healthcare professionals are advised to exercise caution and consider the absence of data when prescribing this medication to women of childbearing potential. It is recommended that the potential risks and benefits be carefully weighed in the context of individual patient circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdose effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of the situation and the necessary steps to take if an accidental ingestion occurs.

Storage and Handling

The product is supplied in a configuration that includes a safety tab, which must remain intact for safe use. It is imperative that the product is not utilized if the safety tab is broken or missing, as this may compromise the integrity and safety of the product.

Storage conditions should be maintained within the recommended temperature range to ensure product stability and efficacy. Special handling precautions should be observed to prevent damage to the packaging and to maintain the product's safety features.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Ez Access, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Ez Access, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.